Drug recall · November 5, 2025
Lisdexamfetamine Dimesylate Capsules recall
Why: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-048-88.
- Lots / codes
Lot #: AD42470, Expiry: 2/28/2026; AD48708, Expiry:4/30/2026.
- Quantity
- N/A
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- U.S Nationwide.
- Initiated
- October 28, 2025 · Voluntary: Firm initiated
- Classified
- October 30, 2025
- Reported
- November 5, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lisdexamfetamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.